Detect syncope, orthostatic tachycardia syndrome (POTS), and autonomic dysfunction with standardized, reproducible testing protocols.

ANS testing helps identify the autonomic basis of unexplained syncope and guide treatment decisions.
Postural Orthostatic Tachycardia Syndrome is detectable with standardized tilt and heart rate variability protocols.
Detect peripheral and autonomic neuropathy with objective, reproducible testing.
Track autonomic function changes over time to monitor neurodegenerative disease progression.
Autonomic nervous system testing is essential in neurology for evaluating unexplained syncope, orthostatic intolerance, postural orthostatic tachycardia syndrome (POTS), small fiber neuropathy, and neurodegenerative conditions like Parkinson's disease and multiple system atrophy. The American Academy of Neurology and the American Autonomic Society recommend standardized testing across all three autonomic domains — cardiovagal (parasympathetic), vasomotor adrenergic (sympathetic), and sudomotor — to establish a complete autonomic profile. VitalScan ANS+ provides neurologists with all four CPT-billable testing modalities (95921–95924) in a single 15-minute session, replacing the need for referral to specialized autonomic laboratories.
Historically, comprehensive autonomic testing required referral to academic neurophysiology suites with tilt tables, QSART chambers, and certified technicians — creating delays of weeks to months and lost revenue for the referring practice. VitalScan ANS+ consolidates the full testing battery into a compact, automated platform that standard clinical staff can operate. CPT 95924 covers combined cardiovagal, vasomotor, and sudomotor testing, providing the highest reimbursement for a single autonomic assessment. By performing testing in-house, neurology practices capture revenue previously lost to referrals, provide faster results to patients, and generate objective data for longitudinal disease monitoring.
US MedResources equips neurology practices nationwide with FDA-cleared autonomic and vascular diagnostic technology. From New York to Los Angeles, Chicago to Miami, practices rely on VitalScan ANS+ for early detection of neurology conditions — with CPT-billable testing that fits into a single patient visit.
Request an ROI & Quote95924Combined autonomic testing: cardiovagal (95921), vasomotor adrenergic (95922), and sudomotor (95923) — the gold standard comprehensive workup for autonomic disorders95921Cardiovagal innervation testing — heart rate variability during deep breathing, Valsalva, and orthostatic challenge for parasympathetic assessment95922Vasomotor adrenergic innervation — beat-to-beat blood pressure response to tilt/standing and Valsalva, critical for syncope and orthostatic intolerance evaluation95923Sudomotor function testing — QSART and electrochemical skin conductance for small fiber and peripheral neuropathy assessmentEstimated monthly revenue
3 tests/day × ~$220 avg = $13,200/month
Based on 3 tests per day, 20 working days per month. Actual reimbursement varies by payer and region.
Adjust the tests you'd run per day and your expected reimbursement for each test type. Your estimated revenue, payback period, and return on investment update instantly.
ANS Comprehensive
CPT 95924
Daily
$600
Sudomotor Function
CPT 95923
Daily
$180
Vascular (ABI / Arterial)
CPT 93922–93924
Daily
$150
Venous Doppler
CPT 93971
Daily
$200
Daily gross revenue
$1,130
5 tests / day
Annual gross reimbursement
$293,800
5 days × 52 weeks
Payback period
2 mo
ROI ratio
6.5X
This mix pays back your $45,000 investment in about 2 months.
Illustrative model based on $45,000 promotional equipment investment and the inputs you choose. Actual reimbursement depends on medical necessity, documentation, payer policy, contracted rates, and claim adjudication. Figures are not a guarantee of reimbursement.
VitalScan ANS+ uses active standing protocols with beat-to-beat blood pressure and heart rate monitoring (CPT 95922) to evaluate orthostatic responses, which is the core diagnostic criterion for POTS. While a full tilt-table study may still be needed in select complex cases, VitalScan provides standardized orthostatic assessment sufficient for the majority of POTS and orthostatic intolerance evaluations — without the space, staff, and time requirements of a tilt table.
Neurologists performing complete autonomic assessment bill CPT 95924, which covers cardiovagal (95921), vasomotor adrenergic (95922), and sudomotor (95923) testing performed together. Individual domains can be billed separately (95921, 95922, or 95923) when only partial testing is performed. Combined testing under 95924 provides the most comprehensive assessment and the highest reimbursement.
Autonomic dysfunction is an early feature of Parkinson's disease, multiple system atrophy (MSA), pure autonomic failure (PAF), and other neurodegenerative conditions. Serial autonomic testing with VitalScan provides objective, reproducible data on disease progression and treatment response — helping neurologists differentiate MSA from Parkinson's, monitor advancing autonomic failure, and adjust management plans based on quantitative rather than subjective assessments.
Get a personalized growth plan with clinical workflow, CPT billing guidance, and financing options — including Section 179 and grant pathways.